Highlight selection of radiochemistry and radiopharmacy developments by editorial board-Reference-Cited by-同舟云学术

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Published:2021-09-08 Issue:1 Volume:6 Page:
ISSN:2365-421X
Container-title:EJNMMI Radiopharmacy and Chemistry
language:en
Short-container-title:EJNMMI radiopharm. chem.

Author:

Alves Francisco,Antunes Inês F.,Cazzola Emiliano,Cleeren Frederik,Cornelissen Bart,Denkova Antonia,Engle Jonathan,Faivre-Chauvet Alain,Gillings Nic,Hendrikx Jeroen J. M. A.,Jalilian Amir R.,van der Meulen Nicholas P.,Mikolajczak Renata,Neels Oliver C.^ORCID,Pillai Maroor R. A.,Reilly Raymond,Rubow Sietske,Seimbille Yann,Spreckelmeyer Sarah,Szymanski Wiktor,Taddei Carlotta

Abstract

Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Funder

Helmholtz-Zentrum Dresden - Rossendorf e. V.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Radiology, Nuclear Medicine and imaging,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1186/s41181-021-00146-9.pdf

Reference42 articles.

1. Alnahwi AH, Tremblay S, Ait-Mohand S, Beaudoin JF, Guérin B. Automated radiosynthesis of 68Ga for large-scale routine production using 68Zn pressed target. Appl Radiat Isot. 2019;156:109014.

2. Aghevlian S, Cai Z, Hedley D, Winnik MA, Reilly RM. Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu. EJNMMI Radiopharm Chem. 2020;5:22.

3. Antunes IF, Franssen GM, Zijlma R, Laverman P, Boersma HH, Elsinga PH. New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals. EJNMMI Radiopharm Chem. 2020;5:1.

4. Carney B, Kossatz S, Reiner T. Molecular imaging of PARP. J Nucl Med. 2017;58:1025–30.

5. Chan CY, Tan KV, Cornelissen B. PARP inhibitors in cancer diagnosis and therapy. Clin Cancer Res. 2021;27:1585–94.